ABCELLERA BIOLOGICS (8QQ) — Cash Flow Quality Index
ABCELLERA BIOLOGICS (8QQ) has a Cash Flow Quality Index of 1.75x as of December 2022. Operating cash flow of €277.36 Million exceeds net income of €158.52 Million, indicating high earnings quality where cash backs reported profits. Explore 8QQ cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ABCELLERA BIOLOGICS Cash Flow Quality Index (2021–2022)
Historical Cash Flow Quality Index for ABCELLERA BIOLOGICS across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ABCELLERA BIOLOGICS cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for ABCELLERA BIOLOGICS (2021–2022)
Year-by-year earnings quality comparison for ABCELLERA BIOLOGICS. For live market cap and the full company financial profile, see ABCELLERA BIOLOGICS stock valuation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.75x | €277.36 Million | €158.52 Million | ▲ +9.8% |
| 2021 | 1.59x | €244.58 Million | €153.46 Million | — |